Delivery Order SPE2DB20D2104-SPE2DB25FMTGW

Award Date 6/13/25
Potential Completion Date 6/16/25
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Timolol 0.5% gel-solution, a pharmaceutical product used for the treatment of glaucoma. The contract has a ceiling value of $2,026.35 and a completion date of March 27, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract has a firm fixed price, a ceiling value of $2,415.07, and an ultimate completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Timolol 0.5% gel-solution, a medication used to treat glaucoma. The contract has a firm fixed price of $1,369.92 and a period of performance through May 14, 2025. The contract is not set-aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.25% Gel-Solution, a medication used to treat certain eye conditions. The contract has a ceiling value of $2,378.70 and a period of performance ending on June 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,090.26 contract is for the supply of Timolol 0.25% Gel-Solution 5ML, a medication used to treat certain eye conditions. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution 5ML, a medication used to treat certain eye conditions. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,234.37 and a period of performance through April 7, 2025. The contract was awarded on April 4, 2025 and does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.53 fixed-price delivery order is for the supply of 5mL bottles of Timolol 0.25% gel-solution, a medication used to treat glaucoma and other eye conditions. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,336.04, is for the supply of Timolol 0.25% Gel-Solution 5ML, a medication used to treat glaucoma. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat certain eye conditions. The contract has a ceiling value of $22,933.67 and a period of performance through February 13, 2024. The contract was awarded on a firm fixed-price basis and was not set aside for any specific...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,021.26 firm fixed-price delivery order is for the supply of TIMOLOL 0.5% GEL-SOLUTION 5ML, a medication used to treat glaucoma. The contract has an ultimate completion date of March 12, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMTGW
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The total ceiling value of the contract is $6,034.95, and the ultimate completion date is June 16, 2025. This contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania, and it holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 9/12/25, 11:04 AM